Total Payments
$105,125
2024 Payments
$4,173
Companies
20
Transactions
119
Payment Breakdown by Category
Consulting$67,830 (64.5%)
Other$15,432 (14.7%)
Travel$11,221 (10.7%)
Food & Beverage$5,531 (5.3%)
Research$5,110 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,830 | 16 | 64.5% |
| Travel and Lodging | $11,221 | 30 | 10.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,212 | 6 | 7.8% |
| Honoraria | $7,220 | 2 | 6.9% |
| Food and Beverage | $5,531 | 59 | 5.3% |
| Unspecified | $5,110 | 6 | 4.9% |
Payments by Type
General
$100,014
113 transactions
Research
$5,110
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $46,879 | 31 | $0 (2022) |
| Novo Nordisk Inc | $17,620 | 20 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $9,021 | 5 | $0 (2023) |
| TOLMAR Pharmaceuticals, Inc. | $7,609 | 9 | $0 (2021) |
| Kowa Research Institute, Inc. | $6,500 | 14 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $5,233 | 7 | $0 (2022) |
| Amarin Pharma Inc. | $4,290 | 2 | $0 (2022) |
| Amgen Inc. | $3,244 | 4 | $0 (2023) |
| Madrigal Pharmaceuticals | $1,470 | 1 | $0 (2024) |
| Lilly USA, LLC | $1,250 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,173 | 8 | Madrigal Pharmaceuticals ($1,470) |
| 2023 | $10,086 | 18 | Janssen Scientific Affairs, LLC ($8,999) |
| 2022 | $8,549 | 5 | SANOFI-AVENTIS U.S. LLC ($4,250) |
| 2021 | $11,186 | 15 | TOLMAR Pharmaceuticals, Inc. ($7,609) |
| 2020 | $2,040 | 1 | Novo Nordisk Inc ($2,040) |
| 2019 | $22,842 | 28 | SANOFI-AVENTIS U.S. LLC ($15,443) |
| 2018 | $15,823 | 21 | Novo Nordisk Inc ($6,216) |
| 2017 | $30,427 | 23 | SANOFI-AVENTIS U.S. LLC ($21,427) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Honoraria | Cash or cash equivalent | $1,470.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | Novo Nordisk Inc | Victoza (Drug) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $114.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $56.15 | General |
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.39 | General |
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $59.07 | General |
| Category: Oncology | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $68.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $96.55 | General |
| 08/12/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Consulting Fee | Cash or cash equivalent | $8,912.50 | General |
| Category: Oncology | ||||||
| 08/12/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $44.00 | General |
| Category: Oncology | ||||||
| 08/12/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Oncology | ||||||
| 08/12/2023 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Oncology | ||||||
| 07/22/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.27 | General |
| Category: Cardiology | ||||||
| 07/22/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $39.80 | General |
| 07/21/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $63.60 | General |
| 06/26/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $96.52 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/25/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $51.05 | General |
| 06/24/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $112.69 | General |
| 06/11/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $48.70 | General |
| Category: Endocrinology | ||||||
| 06/09/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $48.71 | General |
| Category: Diabetes | ||||||
| 06/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $38.12 | General |
| Category: DIABETES | ||||||
| 06/08/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $126.91 | General |
| 06/05/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $59.55 | General |
| 05/19/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $117.39 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PRALUENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $5,110 | 6 |
About Dr. Robert Eckel, MD
Dr. Robert Eckel, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831289503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Eckel, MD has received a total of $105,125 in payments from pharmaceutical and medical device companies, with $4,173 received in 2024. These payments were reported across 119 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($67,830).
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Aurora, CO
- Active Since 10/13/2006
- Last Updated 09/21/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1831289503
Products in Payments
- SOLIQUA (Drug) $21,307
- SOLIQUA 100/33 (Drug) $15,443
- Victoza (Drug) $9,381
- ERLEADA (Drug) $8,999
- ELIGARD (Drug) $7,609
- Vascepa (Drug) $4,290
- SOLIQUA 100/33 (Biological) $4,250
- PRALUENT (Drug) $3,967
- PRALUENT ALIROCUMAB INJECTION (Biological) $3,143
- Repatha (Biological) $3,126
- PRALUENT (Biological) $2,044
- NO PRODUCT DISCUSSED (Drug) $1,792
- RESMETIROM (Drug) $1,470
- MOUNJARO (Drug) $1,250
- Livalo (Drug) $816.23
- LEQVIO (Drug) $182.43
- NEXLIZET (Drug) $130.65
- EVKEEZA (Biological) $122.63
- TOUJEO (Drug) $120.12
- Korlym (Drug) $98.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Aurora
Satish Garg, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.5M
Endocrinology, Diabetes & Metabolism $1.5M
Neda Rasouli, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $269,780
Endocrinology, Diabetes & Metabolism $269,780
James Falko, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $119,791
Endocrinology, Diabetes & Metabolism $119,791
Jane Reusch, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $62,458
Endocrinology, Diabetes & Metabolism $62,458
Bryan Haugen, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $40,153
Endocrinology, Diabetes & Metabolism $40,153
Margaret Wierman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $36,745
Endocrinology, Diabetes & Metabolism $36,745